Q-Line Biotech Limited (NSE:QLINE)

India · Delayed Price · Currency is INR

562.60

+36.75 (6.99%)

At close: Jun 19, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
Manufacturing		1.69B	700.54M	508.72M		-	-
Manufacturing Growth		141.20%	37.71%	-		-	-
Trading		1.45B	1.34B	1.32B		-	-
Trading Growth		8.40%	1.31%	-		-	-
Total		3.14B	2.04B	1.83B		-	-
Total Growth		54.08%	11.44%	-		-	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
North India		2.53B	1.59B	1.42B		-	-
North India Growth		58.66%	11.89%	-		-	-
East India		248.75M	235.95M	194.79M		-	-
East India Growth		5.42%	21.13%	-		-	-
Central Zone		146.90M	94.64M	103.85M		-	-
Central Zone Growth		55.22%	-8.87%	-		-	-
South India		132.16M	59.46M	38.39M		-	-
South India Growth		122.26%	54.90%	-		-	-
West India		80.33M	51.97M	66.22M		-	-
West India Growth		54.57%	-21.52%	-		-	-
Export		3.51M	2.22M	1.15M		-	-
Export Growth		57.69%	93.90%	-		-	-
India		-	-	-		1.71B	850.62M
India Growth		-	-	-		101.51%	3.90%
Total		3.14B	2.04B	1.83B		1.71B	850.62M
Total Growth		54.08%	11.44%	-		101.51%	3.90%